Targovax in phase IIa with cancer vaccine
Immunotherapy specialist Targovax reaches Phase IIa in operable pancreatic cancer with its TG01 immunotherapy. RAS specific immune responses were induced in all 6 patients in Phase I, and no substantial side effects were observed in the patients. The clinical trial has now expanded from Norway to two sites in the UK. Oslo Cancer Cluster […]
Join the Oslo Cancer Cluster Innovation Park & Incubator
May 2015 is THE grand opening of Oslo Cancer Cluster Innovation Park and Oslo Cancer Cluster Incubator. Would you like to join us in the fight against cancer by being part of a power centre for developing innovative cancer treatment? Contact us now, and see what we may offer you as a tenant in the Innovation […]
Nordic Life Science Days and ECCP2014 merge
Oslo Cancer Cluster and French partner Cancer-Bio-Santé are joining forces with SwedenBio to offer the global Life Science industry the largest partnering conference in the Nordics – Nordic Life Science Days featuring the 6th European Cancer Cluster Partnering. Already now oncology biotechs, early stage companies and academics may submit an application for presenting at NLSDays-ECCP […]
5 Oslo Cancer Cluster SMEs granted BIA-funding
The Norwegian Research Council recently granted BerGenBio, PCI Biotech, Lytix Biopharma, Oncoinvent and Ultimovacs – all Oslo Cancer Cluster member companies – funding through the Programme for User-Driven Research Based Innovation (BIA). In total, the Research Council will grant a record amount of 444 million to 58 Norwegian companies over four years, of which 10 are […]
Presentations from cancer nanomedicine seminar
Friday January 31 Oslo Cancer Cluster, SINTEF, NTNU, Oslo University Hospital and the Norwegian Cancer Society invite Norwegian media and other interested parties to join a breakfast seminar on nano cancer medicine. The seminar is held in conjunction with 12 similair events across the whole of Europe in relation to Nano World Cancer Day. Below […]
Trying out life as oncology researchers
Six biology students from Ullern High School were selected to intern at the Department of Tumor Biology at Oslo University Hospital in week 50. This is the fourth time the department has had students from Ullern interning, says researcher Birgit Engesæter. Together with her research colleague Siri Tveito, she is in charge of the students […]
